CLINICAL_TRIALS ClinicalTrials.gov record with results posted

5-5-5 Adaptive Bridging Radiation Therapy (ABRT) for Relapsed/Refractory B-cell Lymphoma Prior to CAR T-cell Therapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06004167
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-10-16T00:03:23.997876+00:00
Published At: 2026-10-15T00:00:00+00:00
Record Updated At: 2026-10-15
Results Posted At: 2026-10-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Lymphoma, B-Cell", "Relapsed Cancer", "Refractory Lymphoma", "Diffuse Large B Cell Lymphoma", "Mediastinal Large B-cell Lymphoma", "High-grade B-cell Lymphoma", "Follicular Lymphoma", "Mantle Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-10-15"
protocolSection.identificationModule.nctId: "NCT06004167"
protocolSection.identificationModule.officialTitle: "5-5-5 Adaptive Bridging Radiation Therapy (ABRT) for Relapsed/Refractory B-cell Lymphoma Prior to CAR T-cell Therapy"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-10-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.